<DOC>
	<DOC>NCT02862054</DOC>
	<brief_summary>To evaluate the clinical value of splenectomy as a treatment for relapsed haemophagocytic lymphohistiocytosis (HLH) in patient with unknown etiology.</brief_summary>
	<brief_title>Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology</brief_title>
	<detailed_description />
	<mesh_term>Lymphohistiocytosis, Hemophagocytic</mesh_term>
	<criteria>1. Patients were older than 14 years of age 2. Diagnosed as Hemophagocytic Lymphohistiocytosis (HLH) according to HLH2004. 3. patients were excluded with infection, rheumatic and immunologic diseases, malignant tumors (especially lymphoma), and primary HLH. 4. Informed consent 1. Pregnancy or lactating Women 2. Active bleeding of the internal organs 3. Uncontrollable infection 4. Contraindication of splenectomy 5. Participate in other clinical research at the same time</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>haemophagocytic lymphohistiocytosis</keyword>
	<keyword>splenectomy</keyword>
	<keyword>unknown etiology</keyword>
</DOC>